Intranasal fluticasone, loratadine tablets, and their use in combination: An evaluation of economic and humanistic outcomes

Drug Benefit Trends

Volumn 13, Issue 10, 2001, Pages

  Howard, K B ^a   Bowers, B W ^a   Cook, C K ^a   Westlund, R ^a   Rickard, K ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Cost effectiveness; Fluticasone propionate; Loratadine; Quality of life; Seasonal allergic rhinitis

Indexed keywords

FLUTICASONE PROPIONATE; LORATADINE; PLACEBO;

ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOUBLE BLIND PROCEDURE; ECONOMIC ASPECT; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOMES RESEARCH; PARALLEL DESIGN; PATIENT SATISFACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEASONAL VARIATION; TABLET;

EID: 0034751709     PISSN: 10805826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Pathophysiology and treatment of seasonal allergic rhinitis
2. Studies on the allergic and nonallergic nasal inflammation
3. Long-term risk factors for developing asthma and allergic rhinitis: A 23-year follow-up of college students
4. An economic evaluation of allergic rhinitis in the United States
5. Treatment of allergic rhinitis: An evidence-based evaluation of nasal corticosteroids versus nonsedating antihistamines
6. Treating allergic rhinitis to prevent long-term complications
7. Mediators of allergic rhinitis
8. A comparison of costs and efficacy of intranasal fluticasone propionate and terfenadine tablets for seasonal allergic rhinitis
9. Seasonal allergic rhinitis and antihistamine effects on children's learning
10. Quality of life (QL) of Kentuckians with allergies or asthma: A statewide survey
11. International Consensus Report on the diagnosis and management of rhinitis
12. Quality of life and rhinitic symptoms: Results of a nationwide survey with the SF-36 and RQLQ questionnaires
13. National health spending trends, 1960-1993
14. Allergic and nonallergic rhinitis
15. Fluticasone propionate given once daily is as effective for seasonal allergic rhinitis as beclomethasone dipropionate given twice daily
16. Fluticasone propionate: An effective alternative treatment for seasonal allergic rhinitis in adults and adolescents
17. Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis
18. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis
19. Fluticasone propionate aqueous nasal spray compared with oral loratadine in patients with seasonal allergic rhinitis
20. Intranasal fluticasone provided better results in patient-rated outcomes than loratadine tablets
21. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: Development and testing of a questionnaire for clinical trials
22. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis
23. Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis
24. First-line treatment of seasonal (ragweed) rhinoconjunctivitis: A randomized management trial comparing a nasal steroid spray and a nonsedating antihistamine